Clinical Trial Update: Study of PD-1 Inhibitor in Combination With Gemcitabine/Cisplatin for Advancer BTCs [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is evaluating a PD-1 inhibitor in combination with gemcitabine and cisplatin for advanced biliary tract cancer; the current status is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Gemcitabine (Gemcitabine)
• PD-1 inhibitor (unspecified)

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: Biliary Tract Cancer | Phase 1, Phase 2 | Status: UNKNOWN